The IPO market showed signs of life after a fairly quiet April, with three IPOs and two SPACs this past week. While there were only two new IPO filings, a few large deals in the pipeline updated their prospectuses, including Corebridge Financial (CRBG) and ...read more
Austin Gold, a Canadian gold exploration company with four properties in Nevada, raised $13 million by offering 3.3 million shares at $4, as expected. Austin Gold is a gold exploration company focused on gold targets and making district-scale gold discoveries...read more
Updated Monday, 5/2.In what would be the second largest IPO of the year, eyecare company Bausch + Lomb (BLCO) is scheduled to debut in the week ahead. Some small issuers and SPACs may also price during the week.Planning to dual list on the NYSE and the TSX,...read more
Updated Monday, 4/25.The April IPO market is expected to close out with norovirus vaccine developer HilleVax (HLVX), along with two healthcare micro-caps. Other small deals and SPACs may join the calendar during the week.HilleVax (HLVX) plans to raise...read more
US IPO Weekly Recap: Bausch + Lomb deal headlines a 3 IPO week
The IPO market showed signs of life after a fairly quiet April, with three IPOs and two SPACs this past week. While there were only two new IPO filings, a few large deals in the pipeline updated their prospectuses, including Corebridge Financial (CRBG) and ...read more
Canadian gold exploration company Austin Gold prices US IPO at $4
Austin Gold, a Canadian gold exploration company with four properties in Nevada, raised $13 million by offering 3.3 million shares at $4, as expected. Austin Gold is a gold exploration company focused on gold targets and making district-scale gold discoveries...read more
US IPO Week Ahead: Bausch + Lomb plans the second largest IPO of 2022
Updated Monday, 5/2.In what would be the second largest IPO of the year, eyecare company Bausch + Lomb (BLCO) is scheduled to debut in the week ahead. Some small issuers and SPACs may also price during the week.Planning to dual list on the NYSE and the TSX,...read more
US IPO Week Ahead: April closes out with 3 healthcare IPOs
Updated Monday, 4/25.The April IPO market is expected to close out with norovirus vaccine developer HilleVax (HLVX), along with two healthcare micro-caps. Other small deals and SPACs may join the calendar during the week.HilleVax (HLVX) plans to raise...read more